Trial Profile
A phase III trial of evogliptin for type 2 diabetes in Indian patients
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 20 Nov 2015
Price :
$35
*
At a glance
- Drugs Evogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 09 Oct 2015 New trial record